BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8218210)

  • 1. Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter.
    Heinrichs AA; Bortell R; Rahman S; Stein JL; Alnemri ES; Litwack G; Lian JB; Stein GS
    Biochemistry; 1993 Oct; 32(42):11436-44. PubMed ID: 8218210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription.
    Aslam F; Shalhoub V; van Wijnen AJ; Banerjee C; Bortell R; Shakoori AR; Litwack G; Stein JL; Stein GS; Lian JB
    Mol Endocrinol; 1995 Jun; 9(6):679-90. PubMed ID: 8592514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box.
    Meyer T; Gustafsson JA; Carlstedt-Duke J
    DNA Cell Biol; 1997 Aug; 16(8):919-27. PubMed ID: 9303434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation.
    Heinrichs AA; Banerjee C; Bortell R; Owen TA; Stein JL; Stein GS; Lian JB
    J Cell Biochem; 1993 Nov; 53(3):240-50. PubMed ID: 8263041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements.
    Owen TA; Bortell R; Shalhoub V; Heinrichs A; Stein JL; Stein GS; Lian JB
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1503-7. PubMed ID: 8381969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter.
    Morrison N; Eisman J
    J Bone Miner Res; 1993 Aug; 8(8):969-75. PubMed ID: 8213259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements.
    Bortell R; Owen TA; Shalhoub V; Heinrichs A; Aronow MA; Rochette-Egly C; Lutz Y; Stein JL; Lian JB; Stein GS
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2300-4. PubMed ID: 8460137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression.
    Bortell R; Owen TA; Bidwell JP; Gavazzo P; Breen E; van Wijnen AJ; DeLuca HF; Stein JL; Lian JB; Stein GS
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6119-23. PubMed ID: 1321435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A.
    van Gurp MF; Pratap J; Luong M; Javed A; Hoffmann H; Giordano A; Stein JL; Neufeld EJ; Lian JB; Stein GS; van Wijnen AJ
    Cancer Res; 1999 Dec; 59(23):5980-8. PubMed ID: 10606245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.
    Goswami R; Lacson R; Yang E; Sam R; Unterman T
    Endocrinology; 1994 Feb; 134(2):736-43. PubMed ID: 7507835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription of the human thyrotropin-releasing hormone receptor gene-analysis of basal promoter elements and glucocorticoid response elements.
    Høvring PI; Matre V; Fjeldheim AK; Loseth OP; Gautvik KM
    Biochem Biophys Res Commun; 1999 Apr; 257(3):829-34. PubMed ID: 10208868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain.
    Frenkel B; Montecino M; Green J; Aslam F; Desai R; Banerjee C; Stein JL; Lian JB; Stein GS
    Endocrinology; 1996 Mar; 137(3):1080-88. PubMed ID: 8603577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
    Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation.
    Strömstedt PE; Poellinger L; Gustafsson JA; Carlstedt-Duke J
    Mol Cell Biol; 1991 Jun; 11(6):3379-83. PubMed ID: 2038339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
    Ray A; LaForge KS; Sehgal PB
    Mol Cell Biol; 1990 Nov; 10(11):5736-46. PubMed ID: 2233715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.
    Leclerc N; Noh T; Khokhar A; Smith E; Frenkel B
    Arthritis Rheum; 2005 Mar; 52(3):929-39. PubMed ID: 15751078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucocorticoid receptor regulates the binding of C/EPBbeta on the alpha-1-acid glycoprotein promoter in vivo.
    Savoldi G; Fenaroli A; Ferrari F; Rigaud G; Albertini A; Di Lorenzo D
    DNA Cell Biol; 1997 Dec; 16(12):1467-76. PubMed ID: 9428795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene.
    Markose ER; Stein JL; Stein GS; Lian JB
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1701-5. PubMed ID: 2308930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.